J8700 HCPCS code: Temozolomide, oral, 5 mg
J8700 is the HCPCS Level II code for temozolomide, oral, 5 mg. In 2024 Medicare paid an average of $0.18 per service for J8700 across 7,514,192 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 120 per day on outpatient hospital claims. Medicare volume rose 51% from 2022 to 2024 (4,983,365 to 7,514,192 services). In 2024, 702 suppliers billed Medicare for J8700 (purchases), serving 5,254 beneficiaries; California, Florida, New York accounted for 24% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2001-01-01 |
| Last action effective | 2018-01-01 |
Who bills J8700 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 702 |
| Referring clinicians | 3,166 |
| Medicare beneficiaries | 5,254 |
| States with claims | 51 |
| Share of services in top 3 states (California, Florida, New York) | 24% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 740 | 5,458 |
| 2023 | 717 | 5,491 |
| 2024 | 702 | 5,254 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J8700, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,983,365 | 5,458 | $0.49 | $0.37 |
| 2023 | 4,997,333 | 5,491 | $0.32 | $0.25 |
| 2024 | 7,514,192 | 5,254 | $0.24 | $0.18 |
States with the most J8700 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 740,855 | $0.18 |
| Florida | 560,799 | $0.18 |
| New York | 481,729 | $0.18 |
| Texas | 478,214 | $0.19 |
| Pennsylvania | 371,982 | $0.18 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 120 | Prescribing Information |
What changed for J8700
- 2001-01-01: J8700 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J8700?
J8700 is the HCPCS Level II code for temozolomide, oral, 5 mg. Short descriptor: "Temozolomide".
How much does Medicare pay for J8700?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.24).
Does Medicare cover J8700?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J8700 can be billed per day?
120 on outpatient hospital claims (NCCI medically unlikely edits).
Related J87 codes
- J8705 — Topotecan, oral, 0.25 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J8700
- Watch J8700 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J8700
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.